Tech Company Financing Transactions
Edge Therapeutics Funding Round
Private investors joined a $118.5 thousand funding round for Edge Therapeutics. The financing round was announced by the company on 9/17/2012.
Transaction Overview
Company Name
Announced On
9/17/2012
Transaction Type
Venture Equity
Amount
$118,500
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
300 Connell Dr. 4000
Berkeley Heights, NJ 07922
USA
Berkeley Heights, NJ 07922
USA
Phone
Undisclosed
Website
Email Address
Overview
Edge Therapeutics, a pharmaceutical company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frank Bedu-Addo
Chief Financial Officer
Andrew Saik
Chief Medical Officer
Lauren Wood
Chief Scientific Officer
Gregory Conn
VP - Administration
Bert Marchio
VP - General Counsel
Brad Middlekauff
VP - Operations
Alpaslan Yaman
VP - Regulatory Affairs
Alyssa Wyant
Browse more venture capital transactions:
Prev: 9/15/2012: Sulia venture capital transaction
Next: 9/17/2012: Revance Therapeutics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs